PT3302573T - Composição para o tratamento de lesões cerebrais - Google Patents

Composição para o tratamento de lesões cerebrais

Info

Publication number
PT3302573T
PT3302573T PT167273648T PT16727364T PT3302573T PT 3302573 T PT3302573 T PT 3302573T PT 167273648 T PT167273648 T PT 167273648T PT 16727364 T PT16727364 T PT 16727364T PT 3302573 T PT3302573 T PT 3302573T
Authority
PT
Portugal
Prior art keywords
treatment
composition
brain lesions
lesions
brain
Prior art date
Application number
PT167273648T
Other languages
English (en)
Inventor
Barritault Denis
Bernaudin Myriam
TOUZANI Omar
TOUTAIN Jérôme
Quittet Marie-Sophie
Original Assignee
Barritault Denis
Luniversite De Caen Basse Normandie
Centre Nat Rech Scient
Organes Tissus Regeneration Reparation Remplacement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Barritault Denis, Luniversite De Caen Basse Normandie, Centre Nat Rech Scient, Organes Tissus Regeneration Reparation Remplacement filed Critical Barritault Denis
Publication of PT3302573T publication Critical patent/PT3302573T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PT167273648T 2015-05-28 2016-05-26 Composição para o tratamento de lesões cerebrais PT3302573T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15305806.0A EP3097928A1 (fr) 2015-05-28 2015-05-28 Composition pour le traitement des lesions cerebrales

Publications (1)

Publication Number Publication Date
PT3302573T true PT3302573T (pt) 2019-10-29

Family

ID=53276045

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167273648T PT3302573T (pt) 2015-05-28 2016-05-26 Composição para o tratamento de lesões cerebrais

Country Status (17)

Country Link
US (1) US20180161372A1 (pt)
EP (2) EP3097928A1 (pt)
JP (1) JP6879941B2 (pt)
KR (1) KR20180043208A (pt)
CN (1) CN107864626A (pt)
AU (1) AU2016266772A1 (pt)
CA (1) CA2992899A1 (pt)
DK (1) DK3302573T3 (pt)
ES (1) ES2755053T3 (pt)
IL (1) IL255692B (pt)
MX (1) MX2017015292A (pt)
PL (1) PL3302573T3 (pt)
PT (1) PT3302573T (pt)
RU (1) RU2710543C2 (pt)
SI (1) SI3302573T1 (pt)
WO (1) WO2016189087A1 (pt)
ZA (1) ZA201707737B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3097922A1 (fr) * 2015-05-28 2016-11-30 Denis Barritault Composition pour le traitement des lesions tissulaires
WO2019237106A1 (en) * 2018-06-08 2019-12-12 University Of Virginia Patent Foundation Compositions and methods for treating stroke
FR3096579B1 (fr) * 2019-05-27 2023-05-05 Organes Tissus Regeneration Reparation Remplacement composition pour la protection et la reparation de la barriere hematoencephalique (BHE)
WO2021181037A1 (fr) * 2020-03-09 2021-09-16 Organes Tissus Regeneration Reparation Remplacement Composition pour le traitement de lesions du systeme respiratoire
CN114317421B (zh) * 2021-12-16 2024-05-03 北京科技大学 强化间充质干细胞促进血管生成的方法、组合物及应用
WO2024124507A1 (en) * 2022-12-15 2024-06-20 Center For Excellence In Brain Science And Intelligence Technology, Chinese Academy Of Sciences Striatal neural progenitors in treatment of hypoxic-ischemic encephalopathy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573251B2 (en) * 1994-03-30 2003-06-03 Denis Barritault Drug and pharmaceutical composition for the treatment of lesions of the nervous system and fractions enriched in heparan sulfate
FR2781485B1 (fr) * 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
EP1513404A4 (en) * 2002-05-30 2006-01-04 Myocardial Therapeutics Inc INTRAMYOCARDIAL INJECTIONS OF AUTOLOGOUS BONE MARROW
US20060104968A1 (en) * 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
FR2979110B1 (fr) * 2011-08-16 2013-09-27 Etat Francais Ministere De La Defense Service De Sante Des Armees Modelisation in vitro des niches medullaires a cellules souches hematopoietiques : un outil pour etudier la regulation de l'hematopoiese, evaluer le potentiel de nichage d'un greffon hematopoietique et tester la pharmaco-toxicologie de medicaments.

Also Published As

Publication number Publication date
CN107864626A (zh) 2018-03-30
KR20180043208A (ko) 2018-04-27
RU2710543C2 (ru) 2019-12-27
RU2017139945A (ru) 2019-06-28
WO2016189087A1 (fr) 2016-12-01
MX2017015292A (es) 2018-05-02
RU2017139945A3 (pt) 2019-09-04
SI3302573T1 (sl) 2019-12-31
DK3302573T3 (da) 2019-11-11
EP3097928A1 (fr) 2016-11-30
EP3302573B1 (fr) 2019-09-11
IL255692A (en) 2018-01-31
JP6879941B2 (ja) 2021-06-02
JP2018516258A (ja) 2018-06-21
AU2016266772A1 (en) 2017-12-14
US20180161372A1 (en) 2018-06-14
PL3302573T3 (pl) 2020-03-31
ZA201707737B (en) 2018-11-28
IL255692B (en) 2021-02-28
CA2992899A1 (fr) 2016-12-01
EP3302573A1 (fr) 2018-04-11
ES2755053T3 (es) 2020-04-21

Similar Documents

Publication Publication Date Title
HK1251257A1 (zh) 用於醫治疾病的外泌體的用途
HK1247202A1 (zh) 用於治療癌症的化合物
IL253945B (en) kdm1a inhibitors to treat the disease
SG11201705093UA (en) Composition for treating il-6-related diseases
IL259996A (en) Combinations for cancer treatment
HUE044021T2 (hu) Akne kezelésére szolgáló készítmény
HK1252996A1 (zh) 用於治療癲癇的方法
HK1245127A1 (zh) 治療腦疾病的方法和組合物
PT3302573T (pt) Composição para o tratamento de lesões cerebrais
IL249640A0 (en) Preparations for the treatment of nosebleeds
ZA201707813B (en) Composition for treating tissue lesions
GB201612043D0 (en) Composition for treatment of disorders
HK1248130A1 (zh) 用於治療疼痛的組合物
EP3362085C0 (en) COMPOSITIONS FOR THE TREATMENT OF DISEASES WITH MUCIN
PT3340975T (pt) Formulação para o tratamento de acne
IL255167A0 (en) Compounds for the treatment of cancer
HUE045225T2 (hu) Formulációk nyálkahártya-léziók kezelésére
IL267059A (en) A preparation for the treatment of osteoarthritis
ZA201704589B (en) Compounds for the treatment of cancer
PT3524255T (pt) Composição para o tratamento do acne
PL3273997T3 (pl) Kompozycja do leczenia nieżytu nosa
AU2015901799A0 (en) Composition for the treatment of skin conditions